Biomarkers as intermediate end points in chemoprevention trials.
Lippman
S M
SM
Department of Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston 77030.
Lee
J S
JS
Lotan
R
R
Hittelman
W
W
Wargovich
M J
MJ
Hong
W K
WK
D014408:Biomarkers, Tumor / Q000032:analysis*; D002338:Carotenoids / Q000627:therapeutic use; D002454:Cell Differentiation; D002455:Cell Division; D002986:Clinical Trials as Topic / Q000379:methods; D004067:Digestive System Neoplasms / Q000517:prevention & control; D006801:Humans; D015162:Micronucleus Tests; D009369:Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology / Q000517:prevention & control*; D012142:Respiratory Tract Neoplasms / Q000517:prevention & control; D012176:Retinoids / Q000627:therapeutic use
D014408:Biomarkers, Tumor; D012176:Retinoids; D002338:Carotenoids